KLK5, kallikrein related peptidase 5, 25818

N. diseases: 59; N. variants: 0
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms
0.330 GeneticVariation group LHGDN Treatment of PC3 prostate cancer cells with mitoxantrone, etoposide, doxorubicin and carboplatin induces distinct alterations in the expression of kallikreins 5 and 11. 19190824 2009
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms
0.330 Biomarker group CTD_human Human tissue kallikrein 5 is a member of a proteolytic cascade pathway involved in seminal clot liquefaction and potentially in prostate cancer progression. 16517595 2006
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms
0.330 Biomarker group LHGDN Human tissue kallikrein 5 is a member of a proteolytic cascade pathway involved in seminal clot liquefaction and potentially in prostate cancer progression. 16517595 2006
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms
0.330 AlteredExpression group LHGDN Down-regulation of the human kallikrein gene 5 (KLK5) in prostate cancer tissues. 11948967 2002